Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT07220343
Status
Recruiting
Apply to this trial

Conditions

  • Adolescents
  • Cancer

Eligibility Criteria

Sex
ALL
Age
10 Years - 25 Years
Healthy Volunteers
Not accepted

Interventions

  • Device — DEVICE
    Participants will wear a wrist-based wearable device for 10 days to passively track physiological data (heart rate, steps, sleep, etc.).
  • Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App — BEHAVIORAL
    Participants will respond to ecological momentary assessments (EMA) via smartphone to actively report on sleep, mood, stress, and eating habits across a 10-day period.

Study Details

The overall goal of the proposed study is to use digital phenotyping to identify and triage at-risk patients and accelerate access to critical mental health services.

Key Dates

Start date
Jan 29, 2025
Status verified
Dec 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Digital Phenotyping Arm
    All participants (adolescents and young adults with cancer) will receive the digital phenotyping intervention, which includes wearing a smartwatch and using a smartphone-based EMA app over a 10-day period, with psychosocial assessments at baseline, day 10, and 2 months

Primary Outcome Measure

Change in Depressive Symptoms (Beck Depression Inventory - BDI) [ Time Frame: Baseline, Day 10, 2 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityPalo AltoCalifornia94304
Olivia Borge
[email protected]
650-723-9392
Victoria Crosgrove, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Palo Alto, CA

By research site
Stanford University· Palo Alto, CA

Related Studies